IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
- 15 February 2011
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 186 (4), 2613-2622
- https://doi.org/10.4049/jimmunol.1003162
Abstract
IL-1F6, IL-1F8, and IL-1F9 and the IL-1R6(RP2) receptor antagonist IL-1F5 constitute a novel IL-1 signaling system that is poorly characterized in skin. To further characterize these cytokines in healthy and inflamed skin, we studied their expression in healthy control, uninvolved psoriasis, and psoriasis plaque skin using quantitative RT-PCR and immunohistochemistry. Expression of IL-1F5, -1F6, -1F8, and -1F9 were increased 2 to 3 orders of magnitude in psoriasis plaque versus uninvolved psoriasis skin, which was supported immunohistologically. Moreover, treatment of psoriasis with etanercept led to significantly decreased IL-1F5, -1F6, -1F8, and -1F9 mRNAs, concomitant with clinical improvement. Similarly increased expression of IL-1F5, -1F6, -1F8, and -1F9 was seen in the involved skin of two mouse models of psoriasis. Suggestive of their importance in inflamed epithelia, IL-1α and TNF-α induced IL-1F5, -1F6, -1F8, and -1F9 transcript expression by normal human keratinocytes. Microarray analysis revealed that these cytokines induce the expression of antimicrobial peptides and matrix metalloproteinases by reconstituted human epidermis. In particular, IL-1F8 increased mRNA expression of human β-defensin (HBD)-2, HBD-3, and CAMP and protein secretion of HBD-2 and HBD-3. Collectively, our data suggest important roles for these novel cytokines in inflammatory skin diseases and identify these peptides as potential targets for antipsoriatic therapies.Keywords
This publication has 53 references indexed in Scilit:
- EGFR and IL-1 Signaling Synergistically Promote Keratinocyte Antimicrobial Defenses in a Differentiation-Dependent MannerJournal of Investigative Dermatology, 2011
- Evidence for Altered Wnt Signaling in Psoriatic SkinJournal of Investigative Dermatology, 2010
- Assessment of the Psoriatic Transcriptome in a Large Sample: Additional Regulated Genes and Comparisons with In Vitro ModelsJournal of Investigative Dermatology, 2010
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences, 2010
- Keratinocyte but Not Endothelial Cell-Specific Overexpression of Tie2 Leads to the Development of PsoriasisThe American Journal of Pathology, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammationThe Journal of Experimental Medicine, 2007
- A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisJournal of the American Academy of Dermatology, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Keratin expression in cultured skin substitutes suggests that the hyperproliferative phenotype observed in vitro is normalized after graftingBurns, 2006